A Science and Technology Blog
Transfer of genes from genetically-modified Aedes aegypti mosquitoes to naturally-occurring ones were seen in Brazil where transgenic mosquitoes were released from June 2013 to September 2015. Contrary to claims made, genes…
The NBRC-led team of researchers has identified the molecular and cellular mechanisms by which Zika virus causes microcephaly. The envelop protein of the virus was responsible for arresting the proliferation of human…
Of the two small molecules tested, IIT Roorkee researchers have found one of them has good antiviral activity against chikungunya virus. The small molecule was able to achieve almost 99% reduction…
Dr. Manu Prakash is once again at his best — solving complex problems in an extraordinarily simple fashion. Using wingbeat sound, location and time of recording, Dr. Prakash and his…
The Piperazine drug used for treating worm infections and HIV has been able to inhibit the replication of chikungunya virus by nearly 98%. A drug to treat chikungunya virus infection is in…
The Asian strain showed greater ability to trigger immune suppression, which allows the virus to replicate and even possibly sneak into the womb and cause more foetal damage. Clinical studies…
The Hyderabad-based Bharat Biotech has begun a Phase I human clinical trial of the indigenously developed chikungunya vaccine three months ago. The vaccine uses a killed virus. The Phase I…
With conventional vector controlling measures against dengue- and Zika-causing Aedes aegypti mosquitoes failing, several countries have started caged and even open field trials using genetically modified mosquitoes. India has signed…
